The Danish biotech firm goes for DKK 37.3 bn in earnings by 2030. “Ascendis is going into a stage of quick development,” chief executive officer claims.
发布者:BY Maria Outze,转转请注明出处:https://robotalks.cn/ascendis-pharma-sees-massive-growth-in-2025-close-to-doubling-revenue/